These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 3101651)
1. Histopathological and morphometrical analysis applied to skin changes in NMRI mice induced by dithranol (anthranil) and its acyl analogs. Kosma VM; Collan Y; Naukkarinen A; Aalto ML; Männistö P Arch Toxicol Suppl; 1986; 9():451-4. PubMed ID: 3101651 [TBL] [Abstract][Full Text] [Related]
2. Tumor-producing activity of dithranol (anthralin) and two of its 10-acyl analogs in the dorsal skin of female NMRI mice. Männistö PT; Vaissi L; Mustakallio KK; Viluksela M; Kosma VM; Collan Y J Pharmacol Exp Ther; 1984 Apr; 229(1):255-60. PubMed ID: 6423812 [TBL] [Abstract][Full Text] [Related]
3. Tumor-producing and skin-irritating activity of dithranol (anthralin) and its 10-acyl analogues in SENCAR mice. Viluksela M; Puotunen E; Newman AJ; Männistö PT Carcinogenesis; 1986 Oct; 7(10):1755-60. PubMed ID: 3757176 [TBL] [Abstract][Full Text] [Related]
4. Dithranol (anthralin)-induced skin irritation in C57BL/6, NMRI and SENCAR mice. Viluksela M; Kosma VM Pharmacol Toxicol; 1991 Aug; 69(2):96-104. PubMed ID: 1775436 [TBL] [Abstract][Full Text] [Related]
5. Correlation of individual papilloma latency time with DNA adducts, 8-hydroxy-2'-deoxyguanosine, and the rate of DNA synthesis in the epidermis of mice treated with 7,12-dimethylbenz[alpha]anthracene. Fischer WH; Lutz WK Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5900-4. PubMed ID: 7597050 [TBL] [Abstract][Full Text] [Related]
6. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression. Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297 [TBL] [Abstract][Full Text] [Related]
7. Toxicological studies with dithranol and its 10-acyl analogues. Männistö PT; Kirkland D; Viluksela M; Tikkanen L Arch Toxicol; 1986 Oct; 59(3):180-5. PubMed ID: 3813885 [TBL] [Abstract][Full Text] [Related]
8. Skin irritation by dithranol (anthralin) and its 10-acyl analogues in 3 animal models. Männistö P; Havas A; Haasio K; Hanhijärvi H; Mustakallio K Contact Dermatitis; 1984 Mar; 10(3):140-5. PubMed ID: 6232099 [TBL] [Abstract][Full Text] [Related]
9. A 6-month dermal toxicity test with dithranol and butantrone in miniature swine. Männistö PT; Hanhijärvi H; Kosma VM; Collan Y Contact Dermatitis; 1986 Jul; 15(1):1-9. PubMed ID: 2944694 [TBL] [Abstract][Full Text] [Related]
10. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen. Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659 [TBL] [Abstract][Full Text] [Related]
11. Pro/antioxidant status and AP-1 transcription factor in murine skin following topical exposure to cumene hydroperoxide. Murray AR; Kisin ER; Kommineni C; Vallyathan V; Castranova V; Shvedova AA Carcinogenesis; 2007 Jul; 28(7):1582-8. PubMed ID: 17234724 [TBL] [Abstract][Full Text] [Related]
12. Genetic susceptibility to tumor progression in mouse skin carcinogenesis. Stern MC; Conti CJ Prog Clin Biol Res; 1996; 395():47-55. PubMed ID: 8895983 [No Abstract] [Full Text] [Related]
13. DNA adducts, cell proliferation and papilloma latency time in mouse skin after repeated dermal application of DMBA and TPA. Fischer WH; Beland PE; Lutz WK Carcinogenesis; 1993 Jul; 14(7):1285-8. PubMed ID: 8330341 [TBL] [Abstract][Full Text] [Related]
14. Influence of diet restriction and tumor promoter dose on cell proliferation, oxidative DNA damage and rate of papilloma appearance in the mouse skin after initiation with DMBA and promotion with TPA. Fischer WH; Lutz WK Toxicol Lett; 1998 Sep; 98(1-2):59-69. PubMed ID: 9776562 [TBL] [Abstract][Full Text] [Related]
15. Antioxidative effects of the spice cardamom against non-melanoma skin cancer by modulating nuclear factor erythroid-2-related factor 2 and NF-κB signalling pathways. Das I; Acharya A; Berry DL; Sen S; Williams E; Permaul E; Sengupta A; Bhattacharya S; Saha T Br J Nutr; 2012 Sep; 108(6):984-97. PubMed ID: 22182368 [TBL] [Abstract][Full Text] [Related]
16. Malignant progression of papillomas induced by the initiation--promotion protocol in NMRI mouse skin. Fürstenberger G; Kopp-Schneider A Carcinogenesis; 1995 Jan; 16(1):61-9. PubMed ID: 7834806 [TBL] [Abstract][Full Text] [Related]
17. Protection against 12-O-tetradecanoylphorbol-13-acetate induced skin-hyperplasia and tumor promotion, in a two-stage carcinogenesis mouse model, by the 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-[2,3-b]quinoxaline analogue of ellipticine. Skarin T; Rozell BL; Bergman J; Toftgård R; Möller L Chem Biol Interact; 1999 Sep; 122(2):89-106. PubMed ID: 10528995 [TBL] [Abstract][Full Text] [Related]
18. Lack of initiation and promotion potential of deoxynivalenol for skin tumorigenesis in Sencar mice. Lambert LA; Hines FA; Eppley RM Food Chem Toxicol; 1995 Mar; 33(3):217-22. PubMed ID: 7896232 [TBL] [Abstract][Full Text] [Related]
19. Dose-time response in mouse skin tumor induction by 7, 12-dimethylbenz[a]anthracene and 12-O-tetradecanoyl-phorbol-13-acetate. Lutz WK; Beland PE; Candrian R; Fekete T; Fischer WH Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 1):44-8. PubMed ID: 8628919 [TBL] [Abstract][Full Text] [Related]
20. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis. La E; Muga SJ; Locniskar MF; Fischer SM Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]